» Articles » PMID: 38398719

Vitamin D Levels As a Marker of Severe SARS-CoV-2 Infection

Abstract

The SARS-CoV-2 virus may cause severe infection, which is associated with diverse clinical manifestations. Vitamin D has immunomodulating properties and may enhance the body's defense system against invading pathogenic organisms. The aim was to assess 25(OH)D levels in patients hospitalized for severe infection from the SARS-CoV-2 virus and explore the relationship between 25(OH)D and outcomes. In a group of 88 patients hospitalized for severe infection from the SARS-CoV-2 virus and a control group matched for age and sex, the levels of 25(OH)D were analyzed. Levels of 25(OH)D were 17.36 ± 8.80 ng/mL (mean ± SD) compared with 24.34 ± 10.34 ng/mL in patients with severe SARS-CoV-2 infection and the control group, respectively, < 0.001 (Student's -test). 25(OH)D levels were significantly related to outcomes, i.e., survival as opposed to non-survival, as more patients with 25(OH)D deficiency (0-10 ng/mL) and insufficiency (10-20 ng/mL) had a fatal outcome as compared with those with vitamin D sufficiency ( < 0.001, chi-square test, < 0.001, Fisher's exact test). Levels of 25(OH)D3 were inversely related to C-reactive protein (CRP), ferritin, d-dimer, and fibrinogen levels ( < 0.001, linear regression analysis, beta coefficient of variation, -0.176, -0.160, -0.178, and -0.158, respectively). Vitamin D deficiency observed in severe SARS-CoV-2 infection was related to disease outcomes.

Citing Articles

Vitamin D and COVID-19: comparative analysis with other respiratory infections and impact of comorbidities.

Constantin L, Ungurianu A, Tarcomnicu I, Balulescu E, Margina D Germs. 2025; 14(3):232-245.

PMID: 39776957 PMC: 11703589. DOI: 10.18683/germs.2024.1435.


Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?.

Cumhur Cure M, Cure E Curr Pharm Des. 2024; 30(15):1149-1156.

PMID: 38566383 DOI: 10.2174/0113816128300162240322075423.

References
1.
Bhatti J, Bhatti G, Khullar N, Reddy A, Reddy P . Therapeutic Strategies in the Development of Anti-viral Drugs and Vaccines Against SARS-CoV-2 Infection. Mol Neurobiol. 2020; 57(11):4856-4877. PMC: 7431281. DOI: 10.1007/s12035-020-02074-2. View

2.
Pinheiro M, Fabbri A, Infante M . Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i). Immunotherapy. 2021; 13(9):753-765. PMC: 8080872. DOI: 10.2217/imt-2020-0349. View

3.
Charoenngam N, Holick M . Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020; 12(7). PMC: 7400911. DOI: 10.3390/nu12072097. View

4.
Decyk A, Kobylinska M, Antosik K, Kurowska K . Vitamin D in SARS-CoV-2 infection. Rocz Panstw Zakl Hig. 2022; 73(1):5-12. DOI: 10.32394/rpzh.2022.0191. View

5.
Hsieh M, Hsiao P, Liao M, Hou Y, Chang Y, Chiang W . The Role of Vitamin D in SARS-CoV-2 Infection and Acute Kidney Injury. Int J Mol Sci. 2022; 23(13). PMC: 9266309. DOI: 10.3390/ijms23137368. View